Date
- Tuesday, 28 February 2012, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
Annual joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. The participants discuss issues in relation to their involvement in the Agency's activities, communication and information, clinical trials and pharmacovigilance.
Documents
Agenda - Patients/Consumers Working Party (PCWP) and Healthcare Professionals Working Group (HCP WG) joint meeting
English (EN) (58.39 KB - PDF)
Minutes Annual Patients/Consumers Working Party (PCWP) and Healthcare Professionals Working Group (HCP WG) joint meeting
English (EN) (85.85 KB - PDF)
Presentation - Professionalisation and representativeness among civil-society representatives
English (EN) (102.63 KB - PDF)
Presentation - Update of questions and answers on biosimilar medicines
English (EN) (515.77 KB - PDF)
Presentation - Public webpage on summary of product characteristics (SmPC)
English (EN) (142.5 KB - PDF)
Presentation - Summary of product characteristics
English (EN) (249.89 KB - PDF)
Presentation - Pandemic lessons learnt
English (EN) (136.91 KB - PDF)
Presentation - The European Clinical Trials Register (EU-CTR V1.1)
English (EN) (165.99 KB - PDF)
Presentation - Pharmacovigilance Working Party: Patients' and consumers' experience
English (EN) (1.08 MB - PDF)
Presentation - Outcome of consultation on additional monitoring of medicines and adverse-drug-reaction reporting – impact on the product information
English (EN) (271.81 KB - PDF)
Presentation - Scientific advisory groups
English (EN) (175.17 KB - PDF)
Presentation - Participation of civil society in scientific advisory groups
English (EN) (119.07 KB - PDF)
Presentation - Scientific advisory group meetings 'pilot phase' report
English (EN) (160.21 KB - PDF)
Presentation - Framework on the interaction between the European Medicines Agency and healthcare professionals
English (EN) (121.53 KB - PDF)
Related information
Contact point
Malika Holleyman
malika.holleyman@ema.europa.eu